- ASSISTANT CLINICAL PROFESSOR | Medicine, Hematology and Medical Oncology
- Hospital Affiliation
- The Mount Sinai Hospital
- Eduardo Saponara, MD, PC 914-793-1500914-793-1500
Business Mailing Address
77 Pondfield Road Bronxville, NY 10708
Internal Medicine 1977
Medical Oncology 1979
Geriatrics 1994 - 2004
Member, Board of Directors, NY Society of Hematologist and Medical Oncologists
Fellow, American College of Physicians
Member, American Society of Clinical Oncologists
Member, American Society of Hematology
Member, American Medical Association
Lecturer in Medicine, Columbia University
Professor, Physical Diagnosis, Columbia University and New York Medical College
International Visiting Professor, Hospital Militar, Lima, Peru
American Board of Internal Medicine
- Anal Cancer
- Biliary Tract And Pancreas
- Breast Cancer
- Carcinoid Tumors
- Chronic Lymphoid Leukemia
- Chronic Myelogenous Leukemia
- Coagulation Disorders
- Colon Cancer
- Esophageal Cancer
- Essential Thrombocythemia
- GIST (Gastrointestinal Stromal Tumor)
- Gastric (Stomach) Cancer
- Genitourinary Malignancies
- Geriatric Oncology
- Gynecologic Malignancies
- Hematologic Malignancies
- Hodgkin's Lymphoma
- Lung Cancer
- Medical Oncology
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Ovarian Cancer
- Prostate Cancer
- Renal Cancer
- Waldenström's Macroglobulinemia
MD, University of Peru-Cayetano Heredia
Internship, Internal Medicine
Residency, Internal Medicine
Westchester Medical Center
Mount Sinai Hospital
English, Italian, Spanish
Dr. Saponara's work focuses on several major topics: breast cancer prevention and treatment, lung, colon, prostate, genitourinary and gastrointestinal cancers, lymphoma, myeloma and leukemia, and hematologic disorders - as well as preventative medicine.
Saponara E, Rothenberg SP, Villamena D. Cytarabine and thioguanine for acute non-lymphocytic leukemia - another look. Arch Intern Med 1979; 139: 1277-1280.
Plasse T, Ohnuma T, Brooks S, Saponara E, Holland J, Biller H. Bleomycin infusion followed by cyclophosphamide, methotrexate and fluorouracil in advanced squamous carcinoma of the head and neck. Cancer 1984; 53: 841-843.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Saponara is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.